Asymmetric, Hydrophobically Modified RNAi Compounds: From Mechanism of Action to Clinical DevelopmentThursday, 19 April 2012 at 16:00 Add to Calendar ▼2012-04-19 16:00:002012-04-19 17:00:00Europe/LondonAsymmetric, Hydrophobically Modified RNAi Compounds: From Mechanism of Action to Clinical DevelopmentSELECTBIOenquiries@selectbiosciences.com This presentation will provide an overview of our recent work to develop sd-rxRNA®, a class of improved RNAi compounds that are readily taken up by cells without any delivery vehicle or formulation. Data supporting the potential therapeutic uses of sd-rxRNA will be presented. |